FTC sues key pharmacy gain professionals above insulin price ranges The company introduced motion against Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the record price of life-saving insulin prescription drugs. The deal needs to be concluded by Sept. 30 or prospective buyers https://label-the-figure-with-the64186.blogcudinti.com/30663253/facts-about-healthcare-news-revealed